Osprey Medical Lands $14,000,000 New Financing Round

  • Feed Type
  • Date
    10/18/2013
  • Company Name
    Osprey Medical
  • Mailing Address
    5600 Rowland Road Minnetonka, MN 55343
  • Company Description
    Osprey Medical’s proprietary technologies are designed to reduce the amount of dye (contrast) injected during commonly performed heart procedures to protect the kidneys from damage known as contrast induced nephropathy (CIN). Dye is routinely used to x-ray the heart during angioplasty and stenting procedures. Patients at high risk of CIN often have pre-existing chronic kidney disease.
  • Website
    http://www.ospreymed.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $14,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The company will use the funding to conduct clinical trials.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.